Parents' perspectives towards paediatric confectionary masked medications: a qualitative study

Andy Jeon1,2,3, Ellen Han4, Kenneth Lee4

  • 1Division of Emergency Medicine, Anaesthesia and Pain Medicine, Medical School, The University of Western, Crawley, Australia.

Insights

Parents support new chocolate-based medications for children, prioritizing taste and safety. Patient education is crucial to prevent misuse of these palatable, confectionary-like medicines.

Area of Science:

  • Pediatric Pharmacology
  • Drug Delivery Systems
  • Patient Experience Research

Background:

  • Limited availability of palatable, age-appropriate oral solid medications for pediatric patients.
  • Development of a novel chocolate-based platform for taste-masking bitter pediatric drugs.
  • Need for understanding parental perspectives on confectionary-like medications.

Purpose of the Study:

  • Identify parental perspectives on taste-masked, confectionary-like medications.
  • Explore barriers and facilitators to oral medication use in children.

Main Methods:

  • Qualitative descriptive study conducted at a tertiary pediatric hospital.
  • Interviews with 17 parents of children aged 2-18 years undergoing elective surgery.
  • Data collected between July and August 2020.

Main Results:

  • Key themes: medication safety and taste.
  • Parents favored the new medication's taste for improved adherence.
  • Concerns regarding medication safety necessitate patient education and appropriate packaging.

Conclusions:

  • Unanimous support for short-term use of taste-masked, confectionary-like medications in hospital settings.
  • Strong parental demand for education on medication use and safety.
  • Emphasis on balancing palatability with robust safety measures for pediatric medications.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
21
Taste Buds and Receptors01:20

Taste Buds and Receptors

Gustation, or the sense of taste, is intrinsically linked to the anatomical structures located on the tongue. This organ's surface, along with the entirety of the oral cavity, is adorned with stratified squamous epithelium. Evident on the tongue are elevated structures known as papillae (singular = papilla), which house the mechanisms for the transduction of gustatory stimuli. Four distinct types of papillae exist, each identified by their unique morphological attributes: the circumvallate,...
3.1K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
29
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
326
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
22
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
23